BioSpace News Archive

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for the three and nine months ending June 2018.

Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that Steven A. Shallcross, Interim Chief Executive Officer & Chief Financial Officer, will present a corporate overview at the 20th Annual Rodman & Renshaw Global

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today reports financial results for the quarter ended July 31, 2018.

Lucideon, the international materials development and commercialization organisation, is pleased to announce that Leah Guenther has been appointed as the new commercial engineer for healthcare.

Turn-Key Health (TKH), an affiliate of Enclara Healthcare, serving health plans, provider organizations and their members who are experiencing a serious or advanced illness, advises accountable care organizations (ACOs) to introduce home-based palliative care as a strategy for achieving success in the Medicare Shared Savings Program (MSSP).

Kewaunee Scientific Corporation (Nasdaq: KEQU) announced that the Company’s Board of Directors promoted Lisa L. Ryan to Vice President of Construction and Customer Operations.

BD (Becton, Dickinson and Company) announced today that it will present at the Morgan Stanley 2018 Global Healthcare Conference on Wednesday, September 12, 2018, at 11:40 a.m. ET.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences

Livestream Fundraising Platform Partners with Top Madden Player Shay Kivlen, Parkland Student Cameron Kasky, & Pro Athletes to Support Shooting Victims’ Families

Management and association expertise will help the ADSO grow and expand.